QIAGEN

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell QIAGEN and other ETFs, options, and stocks.

About QGEN

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Its sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials.

CEO

Thierry L. Bernard

CEOThierry L. Bernard

Employees

5,654

Employees5,654

Headquarters

Venlo, Limburg

HeadquartersVenlo, Limburg

Founded

1996

Founded1996

Employees

5,654

Employees5,654

QGEN Key Statistics

Market cap

7.56B

Market cap7.56B

Price-Earnings ratio

18.95

Price-Earnings ratio18.95

Dividend yield

0.72%

Dividend yield0.72%

Average volume

2.21M

Average volume2.21M

High today

$37.80

High today$37.80

Low today

$36.54

Low today$36.54

Open price

$37.67

Open price$37.67

Volume

1.40M

Volume1.40M

52 Week high

$57.82

52 Week high$57.82

52 Week low

$32.53

52 Week low$32.53

Stock Snapshot

The current QIAGEN(QGEN) stock price is $36.68, with a market capitalization of 7.56B. The stock trades at a price-to-earnings (P/E) ratio of 18.95 and offers a dividend yield of 71.7%.

As of 2026-06-06, QIAGEN(QGEN) stock has fluctuated between $36.54 and $37.80. The current price stands at $36.68, placing the stock +0.4% above today's low and -3.0% off the high.

The QIAGEN(QGEN)'s current trading volume is 1.4M, compared to an average daily volume of 2.21M.

In the last year, QIAGEN(QGEN) shares hit a 52-week high of $57.82 and a 52-week low of $32.53.

QGEN News

Simply Wall St 12h

Evaluating Qiagen After New Bundibugyo Ebolavirus Digital PCR Assays Catch Investor Attention

Advertisement Why Qiagen’s new Bundibugyo ebolavirus assays caught the market’s attention Qiagen (QGEN) recently announced research use digital PCR assays for...

TipRanks 1d

Bank of America Reports 2.84% Voting Interest in QIAGEN - TipRanks

...

TipRanks 1d

UBS reveals 3.04% voting stake in Qiagen after AFM filing

Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis. Discover high-co...

Analyst ratings

55%

of 20 ratings

Buy

45%

Hold

55%

Sell

More QGEN News

Simply Wall St 2d

Is Qiagen’s New Bundibugyo Assays Strategy Quietly Reframing Its Infectious Disease Tools Story?

In May 2026, QIAGEN N.V. announced research-use-only digital PCR assays for its QIAcuity platform to support Bundibugyo ebolavirus research, wastewater surveill...

Simply Wall St 6d

Is It Time To Reconsider Qiagen After Recent Share Price Weakness?

Wondering if Qiagen's share price around US$36.59 reflects a fair deal or a mispricing that could matter for your returns? This article walks through what the v...

People also own

Based on the portfolios of people who own QGEN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.